Sofia Lekka

Dr. Sofia Lekka


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
VPVictoria Psomiadou
Victoria Psomiadou
APAnastasia Prodromidou
Anastasia Prodromidou
AFAlexandros Fotiou
Alexandros Fotiou
SLSofia Lekka
Sofia Lekka
CIChristos Iavazzo
Christos Iavazzo

30 April 2022 in Folia Medica
Verified
Journal Article
Open access
PDF file
VPVictoria Psomiadou
Victoria Psomiadou
CIChristos Iavazzo
Christos Iavazzo
EGEirini Geramani
Eirini Geramani
AFAlexandros Fotiou
Alexandros Fotiou
LKLoukas Karelis
Loukas Karelis
GVGeorge Vorgias
George Vorgias
Uterine angiolipoleiomyomas are rare, benign mixed mesenchymal lesions. A manifestation in the gynecological region is quite uncommon, with few cases described in the literature so far. We present an interesting case of a 59-year-old woman diagnosed with uterine angiolipoleiomyoma, and the results of the conducted systematic review of the literature. The patient presented with a pelvic mass masquerading as a leiomyoma on the ultrasound and postmenopausal vaginal bleeding. At laparotomy, a large uterus was noticed and the histopathology set the diagnosis of angiolipoleiomyoma. Immunohistochemistry revealed negativity for Melan-A and HMB-45 melanoma-specific antibodies and positivity for Van Gieson and orcein histochemical stains. We systematically reviewed the literature. The eligible articles were those written in English, excluding animal studies and studies reporting angiolipoleiomyomas in other regions beside the uterus. The present case is one of the 10 cases of uterine angiolipoleiomyoma reported in the literature. In 8 out of 11 (72.7%) cases, uterine angiolipoleiomyomas arose from the corpus of the uterus, while in 2 (18.1%) cases they were located at the cervix, and in one case (9%) angiolipoleiomyoma was located in the broad ligament. Concerning symptoms, four of the patients (36.4%) presented with abdominal and pelvic pain, two (18.1%) with postmenopausal vaginal bleeding, one with menometrorrhagia (9%), and one with uterine prolapse and cystocele (9%). Immunohistochemical staining of uterine angiolipoleiomyomas was positive for SMA in 4 patients (36.4%), positive for desmin in 3 cases (27.3%), positive for anti-S-100 protein antibody in 2 patients (18.1%), while in one case (9%) immunopositivity was observed for CD31. Only our case (9%) was also tested for CD34, Van Gieson and orcein, the first of these being negative and the other two positive (at the blood vessels in a specialized pattern). Three of the patients (27.3%) were also tested for HMB-45 and all three were immunonegative. In order to establish the diagnosis of uterine angiolipoleiomyomas, ultrasonography and additional MRI may help the preoperative prediction of a benign mass. Immunohistochemistry will show strong positivity of alpha-smooth muscle actin and desmin. Complete abdominal hysterectomy is the preferable treatment.

16 February 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SLSofia Lekka
Sofia Lekka
VPVictoria Psomiadou
Victoria Psomiadou
TPTheodoros Panoskaltsis
Theodoros Panoskaltsis
ETEleni Tsouma
Eleni Tsouma
NNNatasa Novkovic
Natasa Novkovic
GVGeorge Vorgias
George Vorgias
Background: A recent theory supports that high-grade serous epithelial ovarian cancer derives from the fimbrial end of the fallopian tube and during the last decade, a few studies have examined the fallopian tube cytology. Our study aims to determine the cytomorphological characteristics of both benign and non-benign salpingeal samples, in order to establish fallopian cytology as a valuable diagnostic test for women with high risk for development of ovarian/fallopian/peritoneal cancer. Methods: Our study included patients undergoing salpingoophorectomy or total hysterectomy and salpingoophorectomy for any gynecological pathology. Using a soft brush, fallopian tube smears from the fimbrial end were collected ex vivo. The Cytologists of our Institution described the morphological characteristics of the fallopian cells by adopting a proposed Table, which had a calibration system ranging from 3 to 29. This Table is referred to as the CytoSaLPs Score. Our study compared the two diagnostic cytological methods, the one of the conventional cytology and the other using the CytoSaLPs Score, having as gold standard the tubal’s pathological findings. Results: A total of 230 tubal specimens from 144 patients were included in this study. The Score’s mean for the benign and non-benign arm was 12.8 and 18.7 respectively. The cut-off point for both arms was 16.5. The CytoSaLPs Score tool showed significantly higher specificity (87.50% vs. 75.96, p-value < 0.001) and positive predictive value PPV (40.91% vs. 26.47%, p-value < 0.001) compared to conventional cytology. Regarding the accuracy, the Score’s superiority is highlighted (86.96% vs. 76.52%, p-value < 0.001). Conclutions: The evaluation of tubal cytology using the CytoSaLPs Score could be used as a reliable diagnostic method. Further evaluation with larger studies is warranted.

19 March 2021 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
CIC. Iavazzo
C. Iavazzo
VPVictoria Psomiadou
Victoria Psomiadou
AFAlexandros Fotiou
Alexandros Fotiou
APAnastasia Prodromidou
Anastasia Prodromidou
Athanasios DouligerisAthanasios Douligeris
Athanasios Douligeris
GVGeorge Vorgias
George Vorgias

26 November 2020
Verified
Conference Paper
Closed access
SLSofia Lekka
Sofia Lekka
APAnastasia Prodromidou
Anastasia Prodromidou
AFAlexandros Fotiou
Alexandros Fotiou
VPVictoria Psomiadou
Victoria Psomiadou
DGDimitrios Giannoulopoulos
Dimitrios Giannoulopoulos
Christos R. IavazzoChristos R. Iavazzo
Christos R. Iavazzo
Introduction Endometrial cancer (EC) is the most commonly diagnosed gynecological malignancy in the developed countries. Obesity, diabetes mell |

18 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VPVictoria Psomiadou
Victoria Psomiadou
SLSofia Lekka
Sofia Lekka
TPTheodoros Panoskaltsis
Theodoros Panoskaltsis
APAbraham Pouliakis
Abraham Pouliakis
ETEleni Tsouma
Eleni Tsouma
GVGeorge Vorgias
George Vorgias
Objective: Ovarian, fallopian tube, and primary peritoneal cancers are the deadliest gynecological malignancies, largely due to delayed diagnosis, tumor heterogeneity, and lack of effective methods for early detection. Increasing evidence suggests that most high-grade serous ovarian carcinomas originate from the fallopian tube epithelium. Consequently, recent studies have focused on fallopian tube cytology and its correlation with histological findings. We aimed to evaluate the exploratory diagnostic performance of ex vivo fallopian tube cytology and the CytoSaLPs score for detecting adnexal malignancies in women undergoing salpingectomy. Methods: We conducted a prospective observational study including 304 women undergoing salpingectomy or salpingo-oophorectomy for benign or malignant gynecological indications between 2020 and 2023. Ex vivo cytological brushing of the fimbrial end was performed before fixation. The primary endpoint was diagnostic accuracy compared with histology. Secondary endpoints included evaluation of the CytoSaLPs score using receiver operating characteristic analysis. Results: 491 speciments were obtained. Cytological findings were correlated with histology, demonstrating the diagnostic value of tubal cytology. For fallopian tubes, cytology showed a sensitivity of 94.4%, specificity of 71.0%. and accuracy of 72.7%. Ovarian cytology showed lower sensitivity (72.9%) and specificity (70.7%). For the adnexa as a single entity, sensitivity was 76.5% and specificity 70.7%. ROC analysis demonstrated strong performance of the CytoSaLPs Score for fallopian tubes (AUC 82.9%), moderate performance for ovaries (AUC 63.4%), and fair performance for adnexa overall (AUC 69.9%). Conclusion: This exploratory proof-of-concept study suggests that ex vivo fallopian tube cytology combined with the CytoSaLPs score may represent a promising adjunctive approach for future early detection strategies. External validation is required before clinical implementation.